Rezultati - Slocombe, Tom
- Showing 1 - 4 results of 4
-
1
-
2
Receptor-interacting protein 1 kinase inhibition therapeutically ameliorates experimental T cell-dependent colitis in mice od Gobbetti, Thomas, Berger, Scott B., Fountain, Kathryn, Slocombe, Tom, Rowles, Alison, Pearse, Gail, Harada, Isobel, Bertin, John, Haynes, Andrea C., Beal, Allison M.
Izdano 2020Text -
3
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I... od Hillen, Maarten R, Urso, Katia, Koppe, Emma, Lopes, Ana Pinheiro, Blokland, Sofie L M, Pandit, Aridaman, Slocombe, Tom, van Maurik, André, van Roon, Joel A G, Radstake, Timothy R D J
Izdano 2020Text -
4
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice od Pearce, Andrew C., Bamford, Mark J., Barber, Ruth, Bridges, Angela, Convery, Maire A., Demetriou, Constantinos, Evans, Sian, Gobbetti, Thomas, Hirst, David J., Holmes, Duncan S., Hutchinson, Jonathan P., Jayne, Sandrine, Lezina, Larissa, McCabe, Michael T., Messenger, Cassie, Morley, Joanne, Musso, Melissa C., Scott-Stevens, Paul, Manso, Ana Sousa, Schofield, Jennifer, Slocombe, Tom, Somers, Don, Walker, Ann L., Wyce, Anastasia, Zhang, Xi-Ping, Wagner, Simon D.
Izdano 2021Text